بارگذاری

Slzii.com جستجو کردن

جستجو کردن (اخبار)
Results From Phase 3 Study Of Rademikibart In Moderate-To-Severe Atopic Dermatitis To Be Presented In The Late-Breaking Research Session At The 2026 American Academy Of Dermatology (AAD) Annual Meeting
(MENAFN - GlobeNewsWire - Nasdaq) SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect, or the Company), a clinical-stage ...
2026-03-10 09:17:23

چیکار میکنی؟
0.034653902053833


اخبار
اخبار

آخرین اخبار و عناوین
(MENAFN - GlobeNewsWire - Nasdaq) SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect B...
اخبار